Cumberland Partners LTD Boston Scientific Corp Transaction History

Cumberland Partners LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$40.9 - $45.1 $1.37 Million - $1.51 Million	-33,500 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$38.07 - $44.87 $57,105 - $67,305	1,500 Added 4.69%	33,500 $1.42 Million
Q3 2021 Nov 10, 2021	SELL	$41.23 - $45.88 $206,149 - $229,400	-5,000 Reduced 13.51%	32,000 $1.39 Million
Q2 2021 Aug 09, 2021	BUY	$38.58 - $44.24 $77,160 - $88,480	2,000 Added 5.71%	37,000 $1.58 Million
Q1 2021 May 11, 2021	BUY	$35.27 - $39.67 $352,700 - $396,700	10,000 Added 40.0%	35,000 $1.35 Million

Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $82,875 - $104,925	2,500 Added 11.11%	25,000 $899,000
Q3 2020 Nov 03, 2020	SELL	$34.44 - $42.23 $86,100 - $105,574	-2,500 Reduced 10.0%	22,500 $860,000
Q2 2020 Aug 04, 2020	BUY	$30.19 - $39.11 $90,570 - $117,330	3,000 Added 13.64%	25,000 $878,000
Q1 2020 May 13, 2020	BUY	$25.83 - $45.71 $112,360 - $198,838	4,350 Added 24.65%	22,000 $718,000
Q4 2019 Feb 07, 2020	BUY	$37.87 - $45.37 $157,160 - $188,285	4,150 Added 30.74%	17,650 $798,000
Q2 2019 Aug 08, 2019	BUY	$34.91 - $42.98 $471,284 - $580,230	13,500 New	13,500 $580,000

1,319

1.17B

5.92M

5.75M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $110B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Cumberland Partners LTD with notifications on news.